(Q33407440)

26 July 2017

title

A phase II study of gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the bladder (English)

1 reference

transitional cell carcinoma

26 July 2017

1 reference

1 reference

Zeynep Eroglu

1

1 reference

26 July 2017

John P Fruehauf

series ordinal

2

1 reference

26 July 2017

publication date

1 May 2013

1 reference

Cancer Chemotherapy and Pharmacology

26 July 2017

published in

1 reference

26 July 2017

volume

72

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

263-267

1 reference

26 July 2017

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2178-X

Recent advances in treatment of advanced urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2178-X

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2178-X

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2178-X

A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2178-X

Phase II study of cisplatin and paclitaxel in advanced carcinoma of the urothelium: an Eastern Cooperative Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2178-X

Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2178-X

Carboplatin and urothelial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2178-X

Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2178-X

Supraadditive effect of 2',2'-difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2178-X

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2178-X

Single-agent gemcitabine in previously untreated elderly patients with advanced bladder carcinoma: response to treatment and correlation with the comprehensive geriatric assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2178-X

Combination of gemcitabine and oxaliplatin in urothelial cancer patients with severe renal or cardiac comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2178-X

A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2178-X

Treatment of patients with metastatic urothelial cancer "unfit" for Cisplatin-based chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2178-X

Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2178-X

Gemcitabine or Gemcitabine Plus Oxaliplatin in the First-Line Treatment of Patients With Advanced Transitional Cell Carcinoma of the Urothelium Unfit for Cisplatin-Based Chemotherapy: A Randomized Phase 2 Study of the French Genitourinary Tumor Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2178-X

10.1007/S00280-013-2178-X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

1022945188

0 references

1 reference